
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14731237
[patent_doc_number] => 10385007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
[patent_app_type] => utility
[patent_app_number] => 15/837728
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18046
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837728 | Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase | Dec 10, 2017 | Issued |
Array
(
[id] => 14006003
[patent_doc_number] => 10221441
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-03-05
[patent_title] => Compounds and methods for assaying activity of lysosomal storage diseases
[patent_app_type] => utility
[patent_app_number] => 15/837900
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3965
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837900 | Compounds and methods for assaying activity of lysosomal storage diseases | Dec 10, 2017 | Issued |
Array
(
[id] => 12884818
[patent_doc_number] => 20180186781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/836442
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836442 | Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease | Dec 7, 2017 | Issued |
Array
(
[id] => 17133696
[patent_doc_number] => 11135231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Methods and compositions for prevention and treatment of Apicomplexan infections
[patent_app_type] => utility
[patent_app_number] => 16/467320
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14642
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467320 | Methods and compositions for prevention and treatment of Apicomplexan infections | Dec 6, 2017 | Issued |
Array
(
[id] => 16012677
[patent_doc_number] => 20200181181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX
[patent_app_type] => utility
[patent_app_number] => 16/344315
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344315 | Method for producing cyclometalated iridium complex | Dec 3, 2017 | Issued |
Array
(
[id] => 12305766
[patent_doc_number] => 09938287
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-04-10
[patent_title] => Blue fluorescence dopant compound and organic electroluminescent device using the same
[patent_app_type] => utility
[patent_app_number] => 15/828293
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16890
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15828293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/828293 | Blue fluorescence dopant compound and organic electroluminescent device using the same | Nov 29, 2017 | Issued |
Array
(
[id] => 12258734
[patent_doc_number] => 20180077930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'INSECTICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/824099
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35667
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824099
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/824099 | INSECTICIDAL COMPOUNDS | Nov 27, 2017 | Abandoned |
Array
(
[id] => 14831811
[patent_doc_number] => 20190274306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => 2-[3-(ALKYLSULFONYL)-2H-INDAZOL-2-YL]-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 16/463327
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463327 | 2-[3-(alkylsulfonyl)-2H-indazol-2-yl]-3H-imidazo[4,5-B]pyridine derivatives and similar compounds as pesticides | Nov 21, 2017 | Issued |
Array
(
[id] => 12260530
[patent_doc_number] => 20180079726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'BENZIMIDAZOLE DERIVATIVES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/820103
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26876
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820103 | Benzimidazole derivatives and use thereof | Nov 20, 2017 | Issued |
Array
(
[id] => 16955981
[patent_doc_number] => 11059822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => MAGL inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/349047
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46917
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349047 | MAGL inhibitors | Nov 14, 2017 | Issued |
Array
(
[id] => 13091261
[patent_doc_number] => 10064956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/812823
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 26
[patent_no_of_words] => 14329
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812823 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof | Nov 13, 2017 | Issued |
Array
(
[id] => 13289151
[patent_doc_number] => 10155751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Pyrazolyl-substituted heteroaryls and their use as medicaments
[patent_app_type] => utility
[patent_app_number] => 15/809163
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27271
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809163 | Pyrazolyl-substituted heteroaryls and their use as medicaments | Nov 9, 2017 | Issued |
Array
(
[id] => 14246083
[patent_doc_number] => 10273233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Inhibitors of influenza viruses replication
[patent_app_type] => utility
[patent_app_number] => 15/807984
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 23275
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807984 | Inhibitors of influenza viruses replication | Nov 8, 2017 | Issued |
Array
(
[id] => 12233066
[patent_doc_number] => 20180065929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B'
[patent_app_type] => utility
[patent_app_number] => 15/807468
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18629
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807468 | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | Nov 7, 2017 | Issued |
Array
(
[id] => 15209565
[patent_doc_number] => 20190367469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/348304
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348304 | Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators | Nov 7, 2017 | Issued |
Array
(
[id] => 16184432
[patent_doc_number] => 10717736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Pyrrole amides as alpha V integrin inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/347826
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24425
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 936
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347826 | Pyrrole amides as alpha V integrin inhibitors | Nov 6, 2017 | Issued |
Array
(
[id] => 16842848
[patent_doc_number] => 11014922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Cyclobutane- and azetidine-containing mono and spirocyclic compounds as aV integrin inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/347849
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78817
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 946
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347849 | Cyclobutane- and azetidine-containing mono and spirocyclic compounds as aV integrin inhibitors | Nov 6, 2017 | Issued |
Array
(
[id] => 13746605
[patent_doc_number] => 10166227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => Bromodomain and extra-terminal protein inhibitor combination therapy
[patent_app_type] => utility
[patent_app_number] => 15/796571
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 42237
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796571 | Bromodomain and extra-terminal protein inhibitor combination therapy | Oct 26, 2017 | Issued |
Array
(
[id] => 12801643
[patent_doc_number] => 20180159051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => EMITTERS BASED ON OCTAHEDRAL METAL COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/795615
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15795615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/795615 | EMITTERS BASED ON OCTAHEDRAL METAL COMPLEXES | Oct 26, 2017 | Abandoned |
Array
(
[id] => 13410041
[patent_doc_number] => 20180256563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => OLIGOMER-OPIOID AGONIST CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 15/791951
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791951
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791951 | Oligomer-opioid agonist conjugates | Oct 23, 2017 | Issued |